Abstract

Transvenous lead extraction (TLE) has undergone an explosive evolution since its inception as a rudimentary skill with limited technology and therapeutic options. Early techniques involved simple manual traction that frequently proved ineffective for chronically implanted leads, and carried a significant risk of myocardial avulsion, tamponade, and death. The morbidity and mortality associated with these early extraction techniques limited their application to use only in life-threatening situations, such as infection and sepsis. The past four decades, however, have witnessed significant advances in lead extraction technology, resulting in more efficacious techniques and tools, providing the skilled extractor with a well-equipped armamentarium. With the development of the discipline, we have witnessed a growth in the community of TLE experts coincident with a marked decline in the incidence of procedure-related morbidity and mortality, with recent registries at high-volume centers reporting high success rates with exceedingly low complication rates. Future developments in lead extraction are likely to focus on new tools that will allow for us to provide comprehensive device management, develop alternative systems for extraction training, and focus on the design of new leads conceived to facilitate future extraction.

Highlights

  • Transvenous lead extraction (TLE) has undergone an explosive evolution since its inception as a rudimentary skill with limited technology and therapeutic options

  • The expansion of indications for cardiac implantable electronic device (CIED) therapy and an aging population have resulted in an exponential increase in CIED use

  • It is estimated that the demand for transvenous lead extraction (TLE) has

Read more

Summary

Lead management

The expansion of indications for cardiac implantable electronic device (CIED) therapy and an aging population have resulted in an exponential increase in CIED use. With this, observed complications have increased in a disproportionate manner[1,2] because of greater CIED utilization, more frequent device system revisions for complications,[3,4,5] system upgrade,[6,7,8] lead malfunction,[9,10,11,12,13] and longer patient life expectancies. This has mandated a paradigm shift towards premeditated lead management strategies—from implant to removal or replacement.

TLE indications
Class IIa It is REASONABLE to perform the procedure
Functional Leads
Chronic Pain
TLE Strategies
TLE tools
Lead extraction approach
Pulmonary embolism not requiring surgical intervention
Potential complications and management
Findings
Future directions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.